Clinical Trial Update: ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial ACE2016 evaluating EGFR-expressing locally advanced or metastatic solid tumors in adults; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ACE2016

Snippet

Sponsor: Acepodia Biotech, Inc. | Conditions: Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Status: RECRUITING